Estimating the potential survival gains by eliminating socioeconomic and sex inequalities in stage at diagnosis of melanoma

British Journal of Cancer

Volumn 112, Issue , 2015, Pages S116-S123

  Rutherford, M J ^a   Ironmonger, L ^b   Ormiston Smith, N ^b   Abel, G A ^c   Greenberg, D C ^c,d   Lyratzopoulos, G ^c,e   Lambert, P C ^a,f  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Avoidable deaths; Excess mortality models; Sex inequalities; Socioeconomic inequalities

Indexed keywords

ADULT; AGED; CANCER STAGING; FEMALE; HEALTH CARE DISPARITY; HEALTH DISPARITY; HUMAN; MALE; MELANOMA; MIDDLE AGED; MORTALITY; PATHOLOGY; SEX DIFFERENCE; SKIN NEOPLASMS; SOCIAL CLASS; SOCIOECONOMICS; STATISTICAL MODEL; SURVIVAL RATE; UNITED KINGDOM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ENGLAND; FEMALE; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HUMANS; MALE; MELANOMA; MIDDLE AGED; MODELS, STATISTICAL; MORTALITY; NEOPLASM STAGING; SEX FACTORS; SKIN NEOPLASMS; SOCIAL CLASS; SOCIOECONOMIC FACTORS; SURVIVAL RATE;

EID: 85027942811     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2015.50     Document Type: Article

References (39)

1. Abdel-Rahman M, Stockton D, Rachet B, Hakulinen T, Coleman MP (2009) What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable? Br J Cancer 101: S115–S124.
2. Baughan P, O’Neill B, Fletcher E (2009) Auditing the diagnosis of cancer in primary care: the experience in Scotland. Br J Cancer 101(Suppl 2): S87–S91.
3. Be Clear On Cancer—Finding skin cancer early means its easier to treat (2014) http://www.nhs.uk/be-clear-on-cancer/skin-cancer/home.
4. Beeken RJ, Simon AE, von Wagner C, Whitaker KL, Wardle J (2011) Cancer fatalism: deterring early presentation and increasing social inequalities? Cancer Epidemiol Biomarkers Prev 20: 2127–2131.
5. Cancer Research UK Cancer Survival Group (2006) Life tables for cancer survival analysis. Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, UK. Available at www.lshtm.ac.uk/ncde/cancersurvival/tools.
6. Corrie P, Hategan M, Fife K, Parkinson C (2014) Management of melanoma. Br Med Bull 111: 149–162.
7. De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, Trama A, Visser O, Brenner H, Ardanaz E, Bielska-Lasota M, Engholm G, Nennecke A, Siesling S, Berrino F, Capocaccia R. EUROCARE-5 Working Group (2014) Cancer survival in europe 1999-2007 by country and age: results of EUROCARE–5-a population-based study. Lancet Oncol 15: 23–34.
8. Department for Communities and Local Government (2011) English indices of deprivation 2010Department for Communities and Local Government: London, UK.
9. Downing A, Newton-Bishop JA, Forman D (2006) Recent trends in cutaneous malignant melanoma in the yorkshire region of england; incidence, mortality and survival in relation to stage of disease, 1993-2003. Br J Cancer 95: 91–95.
10. Ellis L, Coleman MP, Rachet B (2012) How many deaths would be avoidable if socioeconomic inequalities in cancer survival in England were eliminated? A national population-based study, 1996-2006. Eur J Cancer 48: 270–278.
11. Extracted from CAS1409 (2014) (5 September 2014 snapshot) www.ncin. org.uk/view?rid=2198. Extracted by David Greenberg 8th October, 2014).
12. Hollestein LM, van den Akker SAW, Nijsten T, Karim-Kos HE, Coebergh JW, de Vries E (2012) Trends of cutaneous melanoma in the netherlands: increasing incidence rates among all breslow thickness categories and rising mortality rates since 1989. Ann Oncol 23: 524–530.
13. Jansen L, Eberle A, Emrich K, Gondos A, Holleczek B, Kajter H, Maier W, Nennecke A, Pritzkuleit R, Brenner H. GEKID Cancer Survival Working Group (2014) Socioeconomic deprivation and cancer survival in germany: an ecological analysis in 200 districts in germany. Int J Cancer 134: 2951–2960.
14. Joosse A, de Vries E, Eckel R, Nijsten T, Eggermont AMM, Hölzel D, Coebergh JWW, Engel J. Munich Melanoma Group (2011) Gender differences in melanoma survival: female patients have a decreased risk of metastasis. J Invest Dermatol 131: 719–726.
15. Keeble S, Abel GA, Saunders CL, McPhail S, Walter FM, Neal RD, Rubin GP, Lyratzopoulos G (2014) Variation in promptness of presentation among 10,297 patients subsequently diagnosed with one of 18 cancers: evidence from a national audit of cancer diagnosis in primary care. Int J Cancer 135: 1220–1228.
16. Lambert P.C, Holmberg L, Sandin F, Bray F, Linklater KM, Purushotham A, Robinson D, Møller H (2011) Quantifying differences in breast cancer survival between England and Norway. Cancer Epidemiol 35: 526–533.
17. Lambert PC, Royston P (2009) Further development of flexible parametric models for survival analysis. Stata J 9: 265–290.
18. Li R, Daniel R, Rachet B (2013) How much of socioeconomic differences in survival in patients with breast cancer can be explained by differences in stage of diagnosis and treatment? application of causal mediation analysis to routine data. Lancet 382: S61.
19. Lyratzopoulos G, Abel GA, Brown CH, Rous BA, Vernon SA, Roland M, Greenberg DC (2013a) Socio-demographic inequalities in stage of cancer diagnosis: evidence from patients with female breast, lung, colon, rectal, prostate, renal, bladder, melanoma, ovarian and endometrial cancer. Ann Oncol 24: 843–850.
20. Lyratzopoulos G, Abel GA, McPhail S, Neal RD, Rubin GP (2013b) Measures of promptness of cancer diagnosis in primary care: secondary analysis of national audit data on patients with 18 common and rarer cancers. Br J Cancer 108: 686–690.
21. Lyratzopoulos G, Neal RD, Barbiere JM, Rubin GP, Abel GA(2012) Variation in number of general practitioner consultations before hospital referral for cancer: findings from the 2010 National Cancer Patient Experience Survey in England. Lancet Oncol 13: 353–365.
22. Macleod U, Mitchell ED, Burgess C, Macdonald S, Ramirez AJ (2009) Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers. Br J Cancer 101(Suppl 2): S92–S101.
23. National Cancer Intelligence Network (2012) Anatomical distribution of sites of malignant melanoma including non-sun exposed sites—incidence and trend. National Cancer Intelligence Network. http://www.ncin.org.uk/view?rid=1224.
24. Nelson CP, Lambert PC, Squire IB, Jones DR (2007) Flexible parametric models for relative survival, with application in coronary heart disease. Stat Med 26: 5486–5498.
25. Office for National Statistics (2011) Cancer Survival Rates, Cancer Survival in England, Patients Diagnosed 2005–2009 and Followed Up to 2010. http://www.ons.gov.uk/ons/rel/cancer-unit/cancer-survival-by-cancer-network/patients-diagnosed-in-1996-2009–followed-up-to-2010/cancer-survivalby-cancer-network-sb2.html.
26. Pokhrel A, Martikainen P, Pukkala E, Rautalahti M, Seppa K, Hakulinen T (2010) Education, survival and avoidable deaths in cancer patients in Finland. Br J Cancer 103: 1109–1114.
27. Quaife SL, Forbes LJL, Ramirez AJ, Brain KE, Donnelly C, Simon AE, Wardle J (2014) Recognition of cancer warning signs and anticipated delay in help-seeking in a population sample of adults in the UK. Br J Cancer 110: 12–18.
28. Rachet B, Ellis L, Maringe C, Chu T, Nur U, Quaresm M, Shah A, Walters S, Woods L, Forman D, Coleman MP (2010) Socioeconomic inequalities in cancer survival in England after the NHS cancer plan. Br J Cancer 103: 446–453.
29. Rachet B, Maringe C, Nur U, Quaresma M, Shah A, Woods LM, Ellis L, Walters S, Forman D, Steward J, Coleman MP (2009) Population-based cancer survival trends in england and wales up to 2007: an assessment of the nhs cancer plan for England. Lancet Oncol 10: 351–369.
30. Rachet B, Woods LM, Mitry E, Riga M, Cooper N, Quinn MJ, Steward J, Brenner H, Estève J, Sullivan R, Coleman MP (2008) Cancer survival in England and Wales at the end of the 20th century. Br J Cancer 99(Suppl 1): S2–10.
31. Robb K, Stubbings S, Ramirez A, Macleod U, Austoker J, Waller J, Hiom S, Wardle J (2009) Public awareness of cancer in Britain: a population-based survey of adults. Br J Cancer 101: S18–S23.
32. Rosengren A, Wilhelmsen L (2004) Cancer incidence, mortality from cancer and survival in men of different occupational classes. Eur J Epidemiol 19: 533–540.
33. Royston P, Lambert PC (2011) Flexible Parametric Survival Analysis Using Stata: Beyond the Cox Model. StataCorp LP.
34. Rutherford MJ, Crowther MJ, Lambert PC (2013a) The use of restricted cubic splines to approximate complex hazard functions in the analysis of timeto-event data: a simulation study. J Statist Comput Sim 85: 777–793.
35. Rutherford MJ, Hinchliffe SR, Abel GA, Lyratzopoulos G, Lambert PC, Greenberg DC (2013b) How much of the deprivation gap in cancer survival can be explained by variation in stage at diagnosis: an example from breast cancer in the East of England. Int J Cancer 133: 2192–2200.
36. Seppa K, Hakulinen T, Laara E (2012) Avoidable deaths and random variation in patients’ survival. Br J Cancer 106: 1846–1849.
37. Sobin LH, Fleming ID (1997) TNM classification of malignant tumors, fifth edition. Cancer 80: 1803–1804.
38. Walter FM, Birt L, Cavers D, Scott S, Emery J, Burrows N, Cavanagh G, MacKie R, Weller D, Campbell C (2014) ‘This isn’t what mine looked like‘: a qualitative study of symptom appraisal and help seeking in people recently diagnosed with melanoma. BMJ Open 4(7): e005566.
39. Weyers W (2012) The ‘epidemic’ of melanoma between under-and overdiagnosis. J Cutan Pathol 39: 9–16.